CTRI/2013/12/004223已完成4 期
Assessment of local Interleukin 1β and CCL28 levels and clinical effects of curcumin gel in an experimental gingivitis model. A randomized double blind controlled clinical trial. - CURENEXT
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Systemically healthy individuals
- •Possessing at atleast 20 natural teeth.
- •All the posterior teeth in upper right quadrant excluding the third molar should be present and exhibit periodontal health or gingivitis.
排除标准
- •There should be no teeth with a probing depth > 3mm.
- •Participants with any tobacco use
- •Recent use of antibiotics, aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) during past one month.
- •If they necrotizing periodontal conditions, gross oral pathology, severe unrestored dental caries or clinically significant laboratory abnormalities.
- •Pregnant and lactating mothers
研究者
相似试验
尚未招募
4 期
A Clinical Trial to test a turmeric based product (Curenext) in treating gum disease.CTRI/2011/05/001767Shaju Jacob P20
尚未招募
不适用
A clinical study to evaluate the levels of inflammatory markers around mini-implants which are used during orthodontic treatment.CTRI/2018/05/013863Bianca B Rodrigues
进行中（未招募）
1 期
A single centre phase II study of Interleukin 1 receptor antagonist in the treatment of severe Traumatic Brain Injury - Interleukin-1 Receptor Antagonist in Severe Traumatic Brain InjuryEUCTR2005-005707-42-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge20
已完成
2 期
Interleukin-1 receptor antagonist in severe traumatic brain injuryTraumatic brain injuryInjury, Occupational Diseases, PoisoningIntracranial injuryISRCTN88597330Cambridge University Hospitals NHS Foundation Trust (UK)26
进行中（未招募）
不适用
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.TIACarotid Artery PlaqueCarotid AtherosclerosisNCT05975554Cambridge University Hospitals NHS Foundation Trust30